Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf

BOULDER, CO / ACCESS Newswire / November 6, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn technology-based stabilized hypochlorous acid (HOCl) products for a wide range of …
Jetzt den vollständigen Artikel lesen